Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
Meridian Bioscience has thrived during the COVID-19 pandemic. Can this stock go much higher, or is it time to cash out?
The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.
No podcast episodes available.
VIVO earnings call for the period ending September 30, 2021.
VIVO earnings call for the period ending June 30, 2021.
VIVO earnings call for the period ending March 31, 2021.
VIVO earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.